On Thursday, December 4, 2025, the CRCT will host a seminar dedicated to the latest innovations in liquid biopsy and fragmentomics for oncology, organized by Adelis.
This scientific event will highlight recent advances in circulating cell-free DNA (cfDNA) analysis, fragmentation profiling, and methylation quantification—key technologies that are transforming cancer diagnostics and precision medicine.
Program and speakers:
Naima Hanoun
Assessment of circulating cell-free DNA fragmentation as a biomarker for pancreatic cancer.Catherine Séva
Characterization of cfDNA fragmentome using BIABooster technology in locally advanced esophageal carcinoma.Sarah Figarol & Sandra Serres
Quantification of global DNA methylation levels using capillary electrophoresis and µLAS technology.
This seminar is a unique opportunity for researchers, clinicians, and oncology professionals to discover cutting-edge techniques in liquid biopsy, cfDNA analysis, and cancer biomarker discovery.
More information and registration on https://www.crct-inserm.fr/evenement/seminaire-technologique-biabooster/